Stocks•28 September 2026•
1 min read
Tempest Therapeutics Files Form 8K with SEC
Key Facts
1Tempest Therapeutics filed a Form 8K with the U.S. Securities and Exchange Commission on September 28, 2026.
Tempest Therapeutics filed a Form 8K with the U.S. Securities and Exchange Commission on September 28, 2026. Investing.com reported that the filing is utilized by public companies to notify investors of material corporate events or significant changes.
TPST closed at $0.829 on September 25, 2026, with the stock reaching a day high of $0.8946 and a low of $0.815 during that session. The regulatory submission was made to comply with SEC requirements regarding the disclosure of significant corporate developments.